Kirenol is a diterpenoid extracted from the Chinese herbal medicine . has been used to treat Rheumatoid arthritis (RA) in China for several centuries. RA is characterized by the proliferation of synoviocytes in inflamed synovia, as well as by their expression of inflammatory cytokines. In the present study, we found that Kirenol inhibited the migration, invasion, and proinflammatory of IL-6 secretion of RA-associated synovial fibroblasts (FLS) at a concentration of 100-200 μg/ml . Proinflammatory cytokines production and synovium hyperplasia and cartilage erosion were also inhibited in a collagen-induced arthritis (CIA) mouse model upon Kirenol treatment. Together, our results thus confirm that Kirenol has potent therapeutic efficacy in RA owing to its ability to suppress negative FLS activities.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563775PMC
http://dx.doi.org/10.3389/fimmu.2019.01304DOI Listing

Publication Analysis

Top Keywords

rheumatoid arthritis
8
kirenol
5
kirenol inhibits
4
inhibits function
4
function inflammation
4
inflammation fibroblast-like
4
fibroblast-like synoviocytes
4
synoviocytes rheumatoid
4
arthritis kirenol
4
kirenol diterpenoid
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!